SI
WX

Sensato Investors’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Sensato Investors’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-549,341
Closed -$23.7M – 102
2015
Q3 		$23.7M Buy
549,341
+51,091
+10% +$2.16M 4.44% 1
2015
Q2 		$21.1M Sell
498,250
-174,263
-26% -$7.35M 4.4% 4
2015
Q1 		$26.1M Buy
672,513
+344,759
+105% +$13.3M 5.62% 1
2014
Q4 		$11M Buy
+327,754
New +$11.6M 3.26% 12

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Sensato Investors's WX Position: Q4 2015 in Review

Sensato Investors sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 549,341 shares — an estimated $23.7M sold.

Sensato Investors first reported a position in WX in Q4 2014 and held it in 4 quarters. The position peaked at $26.1M in Q1 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Sensato Investors reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Sensato Investors sold 549,341 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $23.7M.
  • Sensato Investors first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q4 2014 and held it in 4 quarters.
  • Sensato Investors's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $26.1M in Q1 2015.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Sensato Investors's 13F filing for Q4 2015, filed 16 Feb 2016.